Beta Drugs

1,734.30
-47.20
(-2.65%)
Market Cap
1,750.70 Cr
EPS
37.90
PE Ratio
39.27
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
2,326.00
52 Week Low
1,178.00
PB Ratio
9.12
Debt to Equity
0.12
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,667.20
#1 4,00,017.13
35.07
#1 49,887.20
12.06
#1 9,648
-18.99
44.96
6,856.50
1,82,018.53
82.53
8,184.00
0.89
1,600
23.05
66.42
1,515.70
1,22,424.28
23.63
28,409.50
7.12
5,291
30.28
55.73
3,416.70
1,15,636.65
59.85
10,785.70
11.59
1,656
10.91
71.04
1,276.80
1,06,558.04
#1 18.94
28,905.40
12.36
5,578
21.14
44.33
1,002.50
1,00,874.96
21.32
19,831.50
13.82
3,831
-0.19
73.16
2,287.00
94,391.06
48.26
10,615.60
19.57
1,942
-10.91
35.59
1,960.90
89,553.41
26.97
20,141.50
#1 19.94
1,936
#1 112.49
48.59
34,665.00
73,660.71
53.54
6,097.20
10.80
1,201
27.83
68.86
1,132.50
65,775.78
19.08
29,559.20
17.55
3,169
-0.50
48.07
Forecast
Actual
Growth Rate
Revenue Growth
30.36 %
Net Income Growth
18.57 %
Cash Flow Change
32.29 %
ROE
-7.24 %
ROCE
-5.17 %
EBITDA Margin (Avg.)
-12.68 %

Yearly Financial Results

Annual Financials
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
51
66
91
117
185
228
297
0
Expenses
41
54
73
91
141
174
236
0
EBITDA
10
12
18
25
44
54
61
0
Operating Profit %
19 %
18 %
20 %
21 %
23 %
23 %
20 %
0 %
Depreciation
2
3
4
7
7
10
10
0
Interest
1
1
3
2
2
2
3
0
Profit Before Tax
7
8
12
16
34
41
49
0
Tax
0
-0
3
4
10
10
12
0
Net Profit
7
8
9
12
25
31
36
0
EPS in ₹
7.82
9.30
9.79
12.20
25.82
31.95
37.90
0.00

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
50
83
107
118
158
198
254
Fixed Assets
13
18
44
40
55
63
65
Current Assets
32
43
56
68
97
128
178
Capital Work in Progress
1
15
0
3
0
0
0
Investments
0
0
0
0
0
0
0
Other Assets
35
50
63
75
103
136
190
Total Liabilities
50
83
107
118
158
198
254
Current Liabilities
14
32
37
33
49
63
85
Non Current Liabilities
3
9
13
16
17
13
12
Total Equity
33
41
57
69
92
123
157
Reserve & Surplus
24
32
48
59
83
113
148
Share Capital
9
9
10
10
10
10
10

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
12
-9
2
5
7
2
10
Investing Activities
-11
-21
-15
-6
-22
-19
-14
Operating Activities
17
0
8
19
30
23
31
Financing Activities
5
12
9
-8
-1
-3
-8

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,750.35 1,854.00
26 Mar 2025 BONUS Bonus
1:20
26 Mar 2025 1,850.00 1,935.00
21 Dec 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
21 Dec 2024 2,192.00 2,060.05
12 Nov 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
12 Nov 2024 1,892.10 2,178.40
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2024 1,971.30 1,944.15
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 1,693.10 1,676.00

Technical Indicators

RSI(14)
Neutral
46.61
ATR(14)
Volatile
57.84
STOCH(9,6)
Neutral
45.98
STOCH RSI(14)
Neutral
61.73
MACD(12,26)
Bearish
-1.57
ADX(14)
Weak Trend
15.95
UO(9)
Bearish
47.13
ROC(12)
Downtrend And Accelerating
-1.57
WillR(14)
Neutral
-40.34